BackImpact BioMedical Overview

Impact BioMedical Receivables

Impact BioMedical's receivables is $200K.

Get informed when a big investor buys or sells

+ Follow
Receivables
$197000.00
↓ 1.50% YoYΔ $-3000.00 vs prior year quarter

Peer trimmed avg / median

Loading

Impact BioMedical Receivables History

Loading

Impact BioMedical vs. peers: Receivables Comparison

Loading

Impact BioMedical Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Impact BioMedical (IBO) FAQ

As of the most recent data (June 2026), IBO shows a receivables of $200K. That compares with $200K in the prior-year period — down 1.5% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, IBO's receivables is now $200K (was $200K) — a 1.5% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Impact BioMedical is outperforming or lagging.

Tracking IBO's receivables over time shows whether Impact BioMedical is scaling, shrinking, or reshaping that part of the business. The current reading is $200K That compares with $200K in the prior-year period — down 1.5% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this receivables page, Stockcircle has Impact BioMedical's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect receivables (currently $200K) with ownership activity and broader fundamentals.

Impact BioMedical's receivables is $200K; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.